| Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva) P Chinnaiyan, S Huang, G Vallabhaneni, E Armstrong, S Varambally, ... Cancer research 65 (8), 3328-3335, 2005 | 499 | 2005 |
| Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR) combining anti-EGFR antibody with tyrosine kinase inhibitor S Huang, EA Armstrong, S Benavente, P Chinnaiyan, PM Harari Cancer research 64 (15), 5355-5362, 2004 | 497 | 2004 |
| The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy TS Hong, WA Tomé, RJ Chappell, P Chinnaiyan, MP Mehta, PM Harari International Journal of Radiation Oncology* Biology* Physics 61 (3), 779-788, 2005 | 368 | 2005 |
| Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors I Krop, T Demuth, T Guthrie, PY Wen, WP Mason, P Chinnaiyan, ... Journal of clinical oncology 30 (19), 2307-2313, 2012 | 343 | 2012 |
| Modulation of radiation response by histone deacetylase inhibition P Chinnaiyan, G Vallabhaneni, E Armstrong, SM Huang, PM Harari International Journal of Radiation Oncology* Biology* Physics 62 (1), 223-229, 2005 | 289 | 2005 |
| Whole brain radiotherapy for brain metastasis E McTyre, J Scott, P Chinnaiyan Surgical neurology international 4 (Suppl 4), S236, 2013 | 178 | 2013 |
| Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth A Prabhu, B Sarcar, S Kahali, Z Yuan, JJ Johnson, KP Adam, E Kensicki, ... Cancer research 74 (3), 787-796, 2014 | 172 | 2014 |
| The metabolomic signature of malignant glioma reflects accelerated anabolic metabolism P Chinnaiyan, E Kensicki, G Bloom, A Prabhu, B Sarcar, S Kahali, ... Cancer research 72 (22), 5878-5888, 2012 | 164 | 2012 |
| A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 P Chinnaiyan, M Won, PY Wen, AM Rojiani, M Werner-Wasik, HA Shih, ... Neuro-oncology 20 (5), 666-673, 2018 | 128 | 2018 |
| Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines B Sarcar, S Kahali, AH Prabhu, SD Shumway, Y Xu, T Demuth, ... Molecular cancer therapeutics 10 (12), 2405-2414, 2011 | 127 | 2011 |
| Postradiation sensitization of the histone deacetylase inhibitor valproic acid P Chinnaiyan, D Cerna, WE Burgan, K Beam, ES Williams, ... Clinical Cancer Research 14 (17), 5410-5415, 2008 | 126 | 2008 |
| Effectiveness of radiotherapy for elderly patients with glioblastoma J Scott, YY Tsai, P Chinnaiyan, HHM Yu International Journal of Radiation Oncology* Biology* Physics 81 (1), 206-210, 2011 | 123 | 2011 |
| The radiosensitivity index predicts for overall survival in glioblastoma KA Ahmed, P Chinnaiyan, WJ Fulp, S Eschrich, JF Torres-Roca, ... Oncotarget 6 (33), 34414, 2015 | 122 | 2015 |
| Radiation and new molecular agents, part II: targeting HDAC, HSP90, IGF-1R, PI3K, and Ras P Chinnaiyan, GW Allen, PM Harari Seminars in radiation oncology 16 (1), 59-64, 2006 | 92 | 2006 |
| A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma J Huang, R Chaudhary, AL Cohen, K Fink, S Goldlust, J Boockvar, ... Journal of neuro-oncology 142, 537-544, 2019 | 85 | 2019 |
| Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment S Kant, P Kesarwani, A Prabhu, SF Graham, KL Buelow, I Nakano, ... Cell Death & Disease 11 (4), 253, 2020 | 83 | 2020 |
| Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases KA Ahmed, JM Freilich, Y Abuodeh, N Figura, N Patel, S Sarangkasiri, ... Journal of neuro-oncology 118, 179-186, 2014 | 79 | 2014 |
| Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study S Sahebjam, PA Forsyth, ND Tran, JA Arrington, R Macaulay, AB Etame, ... Neuro-oncology 23 (4), 677-686, 2021 | 73 | 2021 |
| Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma P Chinnaiyan, S Chowdhary, L Potthast, A Prabhu, YY Tsai, B Sarcar, ... Neuro-oncology 14 (1), 93-100, 2012 | 71 | 2012 |
| LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases KA Ahmed, JM Freilich, S Sloot, N Figura, GT Gibney, JS Weber, ... Journal of Neuro-oncology 122, 121-126, 2015 | 70 | 2015 |
